Compile Data Set for Download or QSAR
maximum 50k data
Found 485 with Last Name = 'weiske' and Initial = 'j'
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50180955(CHEMBL3818617)
Affinity DataKi:  8nMAssay Description:Competitive inhibition of full length 6xHis-tagged SMYD2 (unknown origin) expressed in Escherichia coli using varying levels of Btn-Ahx-GSRAHSSHLKSKK...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50180955(CHEMBL3818617)
Affinity DataKi:  28nMAssay Description:Uncompetitive inhibition of full length 6xHis-tagged SMYD2 (unknown origin) expressed in Escherichia coli using fixed levels of Btn-Ahx-GSRAHSSHLKSKK...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50611048(BAY-091)
Affinity DataIC50:  1nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 cells assessed as reduction in ADP production preincubate...More data for this Ligand-Target Pair
Ligand InfoPDB
TargetUbiquitin carboxyl-terminal hydrolase 21(Homo sapiens (Human))TBA
LigandPNGBDBM50612991(CHEMBL5279102)
Affinity DataIC50:  2nMAssay Description:Inhibition of human USP21 using ubiquitin rhodamine 110 110 as substrate preincubated for 15 to 20 mins followed by enzyme addition and measured afte...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
LigandPNGBDBM50611049(CHEMBL5280127)
Affinity DataIC50:  2nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 cells assessed as reduction in ADP production preincubate...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283143((2R)—N-[1-{N′-cyano-N-[3-(difluorometho...)
Affinity DataIC50:  2.64nMAssay Description:For the detection of SMYD2 cellular methylation activity an In Cell Western (ICW) assay was established. This assay allows rapid processing of multip...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM50611049(CHEMBL5280127)
Affinity DataIC50:  3nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 cells assessed as reduction in ADP production preincubate...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
LigandPNGBDBM50611048(BAY-091)
Affinity DataIC50:  3nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 cells assessed as reduction in ADP production preincubate...More data for this Ligand-Target Pair
Ligand InfoPDB
LigandPNGBDBM50610997(CHEMBL5276719)
Affinity DataIC50:  5nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 cells assessed as reduction in ADP production preincubate...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
LigandPNGBDBM50610997(CHEMBL5276719)
Affinity DataIC50:  5.5nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 cells assessed as reduction in ADP production preincubate...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283194(Rac-N-[1-(N′-cyano-N-{5-(difluoromethoxy)-2-...)
Affinity DataIC50:  5.55nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 21(Homo sapiens (Human))TBA
LigandPNGBDBM50612991(CHEMBL5279102)
Affinity DataIC50:  6nMAssay Description:Inhibition of human full length USP21 using Btn-Ahx-PNIRFLD-K(Ubi)-LPQQT-GD-amide as substrate preincubated for 15 to 20 mins followed by substrate a...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283173(N-[1-{N′-cyano-N-[2-methoxy-5-(trifluorometh...)
Affinity DataIC50:  6.65nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM50611050(CHEMBL5270765)
Affinity DataIC50:  7nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 cells assessed as reduction in ADP production preincubate...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
TargetUbiquitin carboxyl-terminal hydrolase 21(Homo sapiens (Human))TBA
LigandPNGBDBM50612990(CHEMBL5268828)
Affinity DataIC50:  8nMAssay Description:Inhibition of human USP21 using ubiquitin rhodamine 110 110 as substrate preincubated for 15 to 20 mins followed by enzyme addition and measured afte...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
LigandPNGBDBM50611048(BAY-091)
Affinity DataIC50:  8nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 assessed as reduction in PI4,5P2 production preincubated ...More data for this Ligand-Target Pair
Ligand InfoPDB
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283196(Rac-N-[1-(N′-cyano-N-{2-[(1-methylpiperidin-...)
Affinity DataIC50:  9.09nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283172(Rac-N-[1-{N′-cyano-N-[2-methoxy-5-(trifluoro...)
Affinity DataIC50:  9.98nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProteinase-activated receptor 1(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50181506(CHEMBL3819038)
Affinity DataIC50:  10nMAssay Description:Antagonist activity at PAR1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUbiquitin carboxyl-terminal hydrolase 21(Homo sapiens (Human))TBA
LigandPNGBDBM50612988(CHEMBL5286335)
Affinity DataIC50:  11nMAssay Description:Inhibition of human USP21 using ubiquitin rhodamine 110 110 as substrate preincubated for 15 to 20 mins followed by enzyme addition and measured afte...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
TargetUbiquitin carboxyl-terminal hydrolase 21(Homo sapiens (Human))TBA
LigandPNGBDBM50612990(CHEMBL5268828)
Affinity DataIC50:  12nMAssay Description:Inhibition of human full length USP21 using Btn-Ahx-PNIRFLD-K(Ubi)-LPQQT-GD-amide as substrate preincubated for 15 to 20 mins followed by substrate a...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283169(Rac-N-[1-{N′-cyano-N-[5-(difluoromethoxy)-2-...)
Affinity DataIC50:  12.5nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283143((2R)—N-[1-{N′-cyano-N-[3-(difluorometho...)
Affinity DataIC50:  13nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM50611046(CHEMBL5290005)
Affinity DataIC50:  13nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 cells assessed as reduction in ADP production preincubate...More data for this Ligand-Target Pair
Ligand InfoPDB
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283139(N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]...)
Affinity DataIC50:  13.2nMAssay Description:For the detection of SMYD2 cellular methylation activity an In Cell Western (ICW) assay was established. This assay allows rapid processing of multip...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283139(N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]...)
Affinity DataIC50:  13.5nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM50611049(CHEMBL5280127)
Affinity DataIC50:  14nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 assessed as reduction in PI4,5P2 production preincubated ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
LigandPNGBDBM50610996(CHEMBL5271652)
Affinity DataIC50:  14nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 cells assessed as reduction in ADP production preincubate...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283132(Rac-N-[1-{N′-cyano-N-[3-(difluoromethoxy)phe...)
Affinity DataIC50:  15nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50075102(CHEMBL3414623)
Affinity DataIC50: <15nMAssay Description:Inhibition of SMYD2 (unknown origin) expressed in Escherichia coli BL21 (DE3) using Biotinaminohexanoyl-GSRAHSSHLKSKKGQSTSRH as substrate after 75 mi...More data for this Ligand-Target Pair
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283195(Rac-N-[r-(N′-cyano-N-[2-[2-(pyrrolidin-1-yl)...)
Affinity DataIC50:  15.8nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM50611048(BAY-091)
Affinity DataIC50:  16nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 assessed as reduction in PI4,5P2 production preincubated ...More data for this Ligand-Target Pair
Ligand InfoPDB
TargetMitogen-activated protein kinase 7(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50508008(CHEMBL4438379)
Affinity DataIC50:  17nMAssay Description:Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin carboxyl-terminal hydrolase 21(Homo sapiens (Human))TBA
LigandPNGBDBM50612988(CHEMBL5286335)
Affinity DataIC50:  18nMAssay Description:Inhibition of human full length USP21 using Btn-Ahx-PNIRFLD-K(Ubi)-LPQQT-GD-amide as substrate preincubated for 15 to 20 mins followed by substrate a...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50180967(CHEMBL3818487)
Affinity DataIC50:  19nMAssay Description:Inhibition of SMYD2 (unknown origin) using H4 as substrate after 2hrs in presence 3H-SAM of by scintillation proximity assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50611047(CHEMBL5277824)
Affinity DataIC50:  19nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 cells assessed as reduction in ADP production preincubate...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283184(N-[1-{N′-cyano-N-[3-(difluoromethoxy)-5-fluo...)
Affinity DataIC50:  19.2nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM50611050(CHEMBL5270765)
Affinity DataIC50:  20nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 cells assessed as reduction in ADP production preincubate...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
TargetMitogen-activated protein kinase 7(Homo sapiens (Human))
Bayer

Curated by ChEMBL
LigandPNGBDBM50508013(CHEMBL4541479)
Affinity DataIC50:  20nMAssay Description:Inhibition of His-tagged MAP2K5 activated N-terminal GST-tagged recombinant human ERK5 (1 to 398 residues) expressed in Escherichia coli using biotin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283172(Rac-N-[1-{N′-cyano-N-[2-methoxy-5-(trifluoro...)
Affinity DataIC50:  21.3nMAssay Description:For the detection of SMYD2 cellular methylation activity an In Cell Western (ICW) assay was established. This assay allows rapid processing of multip...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283205(N-[3-(4-Chloro-3-methylphenyl)-1-{N′-cyano-N...)
Affinity DataIC50:  22.9nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283173(N-[1-{N′-cyano-N-[2-methoxy-5-(trifluorometh...)
Affinity DataIC50:  23.6nMAssay Description:For the detection of SMYD2 cellular methylation activity an In Cell Western (ICW) assay was established. This assay allows rapid processing of multip...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283197(Rac-N-[1-(N′-cyano-N-{2-[(1-methylpiperidin-...)
Affinity DataIC50:  26.1nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM50610997(CHEMBL5276719)
Affinity DataIC50:  27nMAssay Description:Inhibition of recombinant full length His-tagged PIP4K2A (unknown origin) expressed in sf21 assessed as reduction in PI4,5P2 production preincubated ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50180955(CHEMBL3818617)
Affinity DataIC50:  27nMAssay Description:Inhibition of full length 6xHis-tagged SMYD2 (unknown origin) expressed in Escherichia coli using Btn-Ahx GSRAHSSHLKSKKGQSTSRH-amide as substrate aft...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283169(Rac-N-[1-{N′-cyano-N-[5-(difluoromethoxy)-2-...)
Affinity DataIC50:  27.7nMAssay Description:For the detection of SMYD2 cellular methylation activity an In Cell Western (ICW) assay was established. This assay allows rapid processing of multip...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 21(Homo sapiens (Human))TBA
LigandPNGBDBM50612984(CHEMBL5277351)
Affinity DataIC50:  28nMAssay Description:Inhibition of human USP21 using ubiquitin rhodamine 110 110 as substrate preincubated for 15 to 20 mins followed by enzyme addition and measured afte...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails PubMed
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50181508(CHEMBL3818083 | US10023539, Example 4.2)
Affinity DataIC50:  28.2nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM50181508(CHEMBL3818083 | US10023539, Example 4.2)
Affinity DataIC50:  28.2nMpH: 9.0Assay Description:SMYD2 inhibitory activities of the compounds described in the present invention were quantified using a scintillation proximity assay (SPA) which mea...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetN-lysine methyltransferase SMYD2(Homo sapiens (Human))
Bayer Pharma

Curated by ChEMBL
LigandPNGBDBM283170(N-[1-{N′-cyano-N-[5-(difluoromethoxy)-2-meth...)
Affinity DataIC50:  28.7nMAssay Description:For the detection of SMYD2 cellular methylation activity an In Cell Western (ICW) assay was established. This assay allows rapid processing of multip...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 485 total ) | Next | Last >>
Jump to: